| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 刘浩 | 华创证券 | 医药生物 | 67.87% | 54.91% | 33.71% | 29.41% | 2 | -47.33% | 2025-06-06 |
| 2 | 阳景 | 浦银国际证券 | 医药生物 | 67.75% | 41.96% | 27.60% | 100.00% | 4 | 0.00% | 2025-09-04 |
| 3 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 67.36% | 63.05% | 47.80% | 12.50% | 6 | -27.10% | 2025-05-29 |
| 4 | 唐寅灏 | 中信证券 | 医药生物 | 67.25% | 49.09% | 18.08% | 85.71% | 13 | -8.47% | 2025-09-23 |
| 5 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 67.14% | 67.29% | 40.00% | 12.50% | 7 | -27.10% | 2025-06-25 |
| 6 | 顾资然 | 中信证券 | 医药生物 | 67.08% | 62.29% | 53.36% | 66.67% | 6 | -1.79% | 2025-09-04 |
| 7 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 67.07% | 64.15% | 27.12% | 12.50% | 7 | -27.10% | 2025-06-27 |
| 8 | 唐寅灏 | 中信证券 | 医药生物 | 67.02% | 74.95% | 42.31% | 85.71% | 13 | -8.47% | 2025-07-16 |
| 9 | 顾资然 | 中信证券 | 医药生物 | 66.85% | 62.89% | 54.81% | 66.67% | 6 | -1.79% | 2025-09-08 |
| 10 | 唐寅灏 | 中信证券 | 医药生物 | 66.81% | 9.50% | -3.94% | 85.71% | 2 | -8.47% | 2025-12-11 |
| 11 | 王道 | 申万宏源 | 医药生物 | 66.73% | 60.86% | 51.79% | 33.33% | 4 | -42.73% | 2025-09-16 |
| 12 | 唐寅灏 | 中信证券 | 医药生物 | 66.66% | 51.48% | 18.86% | 85.71% | 13 | -8.47% | 2025-09-26 |
| 13 | 顾资然 | 中信证券 | 医药生物 | 66.37% | 66.39% | 52.99% | 66.67% | 6 | -1.79% | 2025-09-01 |
| 14 | 阳景 | 浦银国际证券 | 医药生物 | 66.31% | 35.88% | 33.00% | 100.00% | 3 | 0.00% | 2025-08-26 |
| 15 | 夏禹 | 国联民生 | 医药生物 | 66.19% | 49.44% | 9.21% | 20.00% | 7 | -52.01% | 2025-09-05 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 66.16% | 50.55% | 38.97% | 29.41% | 2 | -47.33% | 2025-06-04 |
| 17 | 唐寅灏 | 中信证券 | 医药生物 | 65.89% | 41.41% | 16.28% | 85.71% | 13 | -8.47% | 2025-09-29 |
| 18 | 阳景 | 浦银国际证券 | 医药生物 | 65.89% | 33.14% | -2.61% | 100.00% | 4 | 0.00% | 2025-10-29 |
| 19 | 王道 | 申万宏源 | 医药生物 | 65.84% | 60.00% | 51.85% | 33.33% | 4 | -42.73% | 2025-09-15 |
| 20 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 65.77% | 61.54% | 28.01% | 12.50% | 7 | -27.10% | 2025-06-19 |